Optical Genome Mapping (OGM) Market Size & Share 2024 to 2032

Optical Genome Mapping Market Size

Optical Genome Mapping Market was valued at USD 131.5 million in 2023 and is estimated to grow at a CAGR of 24.1% between 2024 and 2032. High market share can be attributed to factors such as increasing demand for precision medicine, rising government initiatives & funding, and growing collaborations between technology providers for genomic services.

Also, advancements in optical mapping technologies such as improvements in speed, accuracy, and scalability, contribute significantly to the market's expansion. For instance, in January 2023, Bionano Genomics, Inc, launched multiple new products and advancements for its optical genome mapping (OGM) workflow that offer enhanced robustness in sample preparation. This enable to decrease the turnaround time for DNA labelling and imaging, and improvements in throughput and quality metrics. Thus, availability of such products and services along with the rising prevalence of genetic disorders & cancers has fuelled the need for advanced genomic tools, thereby accelerating the market expansion.
 

Optical genome mapping is a genomic technology that involves the analysis and mapping of DNA molecules at a high resolution. It provides a comprehensive view of the structure and arrangement of genomic DNA. By analysing the patterns and lengths of labelled DNA fragments, researchers can create a detailed map of the genome, identifying structural variations, copy number variations, and other genomic features.
 

COVID-19 Impact

The COVID-19 pandemic had a moderately positive impact on the optical genome mapping market. The urgency to understand the genomic makeup of the SARS-CoV-2 virus and its variants led to an acceleration of genomic research. OGM's ability to provide rapid and high-resolution genomic data became valuable for identifying and monitoring emerging variants of the virus. Furthermore, rapid development of COVID-19 vaccines and antiviral drugs relied on comprehensive genomic data, and technologies including optical genome mapping contributed to these efforts.
 

Optical Genome Mapping Market Trends

• Rising government initiatives and funding play a pivotal role in driving the market size. Government funding facilitates the development of cutting-edge technologies and instrumentation for optical genome mapping. This encourages innovation and contributes to the continuous evolution of optical genome mapping platforms.
   
• Additionally, government-led genomic initiatives such as national precision medicine programs and large-scale genome sequencing projects, create significant demand for advanced genomics technologies like optical genome mapping.
   

However, the substantial financial investment required for acquiring and maintaining optical genome mapping instruments, along with associated services, poses a challenge for research institutions, laboratories, and healthcare facilities that may hinder the market progress.
 

Optical Genome Mapping Market Analysis

Based on products & services, the global market is segmented into services & software, instruments, and consumables & reagents. The services & software segment held the largest market share of 46.5% in 2023.
 

• Services & software providers offer tailored solutions to meet specific research or clinical needs. Customized services, including data processing and interpretation during optical genome mapping enhances the value proposition and provides the accurate readings and results. Additionally, services & software facilitates data visualization, structural variation analysis, and annotation, making it an integral part of the overall optical genome mapping ecosystem.
   
• Furthermore, these services & software provides the valuable insights pertaining to formulation, implementation, and analysis of OGM data in the form of records that can be stored. Such factors are driving the dominance of this segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the optical genome mapping market is bifurcated into research and diagnostics. The research segment held the largest market revenue of USD 89.9 million in 2023.
 

• Researchers often utilize these technologies to gain insights into disease mechanisms. Therefore, OGM plays a crucial role in identifying structural variations, genomic rearrangements, and other genetic abnormalities associated with various diseases, including cancer.
   
• Moreover, the growing awareness among researchers accompanied with training programs and educational initiatives about the capabilities and benefits of optical genome mapping contributes to its dominance in the research segment.
   

Based on solution, the optical genome mapping market is classified into structural variant detection, genome assembly, microbial strain typing, and other solutions. The structural variant detection segment is expected to reach the largest market revenue of USD 414.9 million by 2032.
 

• Structural variant detection is crucial for identifying genomic rearrangements associated with various genetic disorders, cancers, and inherited diseases. Also, in clinical diagnostics, the ability to detect structural variants supports accurate disease diagnosis and prognosis. Therefore, identifying somatic variations and chromosomal rearrangements aids in characterizing cancer subtypes, predicting patient outcomes, and guiding targeted therapies.
   
• Thus, usage of OGM in the various diagnostics and research application is expected to augment the market trends.
   

Based on end-user, the optical genome mapping market is segmented into pharmaceutical & biotechnology companies, research & academic institutes, diagnostic laboratories, and other end-users. The research & academic institutes segment dominated the market in 2023 and is anticipated to grow at CAGR of 23.2% over the forecast years.
 

• Research & academic institutes are often at the forefront of genomic research. They conduct studies and experiments to explore the applications, efficiency, and potential innovations in optical genome mapping technologies.
   
• Also, these institutions play a vital role in training the next generation of scientists, researchers, and genomic experts. They offer educational programs, courses, and workshops that cover optical genome mapping techniques, ensuring a skilled workforce capable of advancing the field.
   

In 2023, North America held a significant share of 43.3% in the optical genome mapping market.
 

• The region comprises several research institutions, universities, and academic centers that lead in genomics research. These institutions drive advancements in genomic technologies, including optical genome mapping, through extensive research and development initiatives.
   
• Furthermore, robust funding mechanisms, including government grants, private investments, and venture capital, support genomics research and technology development in North America. This financial support enables companies and research institutions to invest in advance optical genome mapping technologies. Such aforementioned factors are expected to propel the demand for optical genome mapping in the North American market.
   

Optical Genome Mapping Market Share

The optical genome mapping industry is characterized by diverse players competing in the healthcare industry. Bionano Genomics, Inc., Nucleome Informatics Private Limited, and Nabsys, Inc, account for significant market share. These prominent players adopt a combination of strategic initiatives such as investing in research and development, technological advancements, geographical expansion, product diversification, and regulatory compliance to maintain a competitive edge in the market.
 

Optical Genome Mapping Market Companies

The foremost players operating in the optical genome mapping industry is as mentioned below:

• Bionano Genomics, Inc.
• Nucleome Informatics Private Limited
• Nabsys, Inc.
• Praxis Genomics LLC
• PerkinElmer, Inc.
• OpGen, Inc.
• SourceBio International Limited
• MedGenome Labs Private Limited
• Genohub Inc.
• Cerba HealthCare
   

Optical Genome Mapping Industry News:

• In July 2023, Cerba Healthcare launched a new test in the field of optical genome mapping. The test is a New Generation Cytogenetic diagnostic that allows the analysis of the chromosome structure at a high resolution (up to 500 bp) for balanced and unbalanced structural variants. This strategy is expected to help the company to expand its portfolio.
   
• In March 2023, Bionano Genomics Inc, expanded its clinical testing menu with the launch of OGM-based Laboratory Developed Tests (LDTs) for prenatal and postnatal analysis. This strategy is anticipated to enable the company to expand its service offerings.
   

The optical genome mapping market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Products & Services, 2018 – 2032 (USD Million)

• Instruments
• Consumables & reagents
• Services & software

By Application, 2018 – 2032 (USD Million)

• Research
• Diagnostics

By Solution, 2018 – 2032 (USD Million)

• Structural variant detection
• Genome assembly
• Microbial strain typing
• Other solutions

By End-user, 2018 – 2032 (USD Million)

• Pharmaceutical & biotechnology companies
• Research & academic institutes
• Diagnostic laboratories
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa